J.L. Llisterri

4.1k total citations
130 papers, 2.3k citations indexed

About

J.L. Llisterri is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, J.L. Llisterri has authored 130 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Cardiology and Cardiovascular Medicine, 44 papers in Surgery and 26 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in J.L. Llisterri's work include Blood Pressure and Hypertension Studies (97 papers), Heart Rate Variability and Autonomic Control (34 papers) and Cardiovascular Syncope and Autonomic Disorders (30 papers). J.L. Llisterri is often cited by papers focused on Blood Pressure and Hypertension Studies (97 papers), Heart Rate Variability and Autonomic Control (34 papers) and Cardiovascular Syncope and Autonomic Disorders (30 papers). J.L. Llisterri collaborates with scholars based in Spain, Germany and United States. J.L. Llisterri's co-authors include Vivencio Barrios, Josep Redón, G.C. Rodríguez Roca, Vicente Pallarés‐Carratalá, J.A. Divisón, José Vicente Lozano, José Aznar, Francisco Javier Alonso Moreno, Salvador Lou Arnal and Luis Cea‐Calvo and has published in prestigious journals such as Stroke, Hypertension and International Journal of Environmental Research and Public Health.

In The Last Decade

J.L. Llisterri

122 papers receiving 2.2k citations

Peers

Countries citing papers authored by J.L. Llisterri

Since Specialization

Citations

This map shows the geographic impact of J.L. Llisterri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.L. Llisterri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.L. Llisterri more than expected).

Fields of papers citing papers by J.L. Llisterri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.L. Llisterri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.L. Llisterri. The network helps show where J.L. Llisterri may publish in the future.

Co-authorship network of co-authors of J.L. Llisterri

This figure shows the co-authorship network connecting the top 25 collaborators of J.L. Llisterri. A scholar is included among the top collaborators of J.L. Llisterri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.L. Llisterri. J.L. Llisterri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prevalence of chronic kidney disease and associated factors in the Spanish population attended in primary care: Results of the IBERICAN study 2021 ·Medicina Clínica (English Edition) ·J.L. Llisterri, R.M. Micó-Pérez, (unknown), (unknown), Miguel Ángel Prieto-Díaz, Vicente Martín, Alfonso Barquilla-García, José Polo García, Antonio Segura‐Fragoso, Sergio Cinza‐Sanjurjo	4
2	Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease 2021 ·BMC Nephrology ·José Luis Górriz, David Arroyo, Luis D’Marco, Roser Torrá, (unknown), María Jesús Puchades, Nayara Panizo, (unknown), (unknown), J.L. Llisterri, Vicente Pallarés‐Carratalá, José Manuel Valdivielso	6
3	La maldita pandemia: una oportunidad para la Atención Primaria de Salud 2020 ·Medicina de Familia SEMERGEN ·J.L. Llisterri	5
4	La pandemia por la COVID-19: una oportunidad para cambiar la forma de atender a nuestros pacientes 2020 ·Medicina de Familia SEMERGEN ·Vicente Pallarés‐Carratalá, (unknown), J.L. Llisterri, José Luis Górriz	15
5	Grado de control y cumplimiento terapéutico de la anticoagulación con acenocumarol en Atención Primaria 2015 ·Medicina de Familia SEMERGEN ·(unknown), (unknown), (unknown), (unknown), (unknown), J.L. Llisterri	11
6	Treatment and blood pressure control in Spain during 2002–2010 2012 ·Journal of Hypertension ·J.L. Llisterri, (unknown), Carlos Escobar, (unknown), M. Prieto, Vivencio Barrios, Diego González-Segura Alsina, J.A. Divisón, Vicente Pallarés‐Carratalá, (unknown)	51
7	Inercia terapéutica en pacientes hipertensos asistidos en atención primaria en España. Estudio Objetivo Kontrol 2011 ·Atención Primaria ·(unknown), J.L. Llisterri, (unknown), Francisco Javier Alonso Moreno, (unknown), (unknown), (unknown), (unknown), (unknown), Pablo Mercado	10
8	Autopercepción de la salud cardiovascular de los médicos de atención primaria. Estudio CHABS 2011 ·Medicina Clínica ·José R. Banegas, José María Lobos, J.L. Llisterri, (unknown)	4
9	Impacto de la presencia de enfermedad cardiovascular en el control de presión arterial y lípidos en la población hipertensa asistida en atención primaria 2008 ·Atención Primaria ·Vivencio Barrios, Carlos Escobar, (unknown), J.L. Llisterri, (unknown), (unknown)	6
10	Tolerability of High Doses of Lercanidipine versus High Doses of Other Dihydropyridines in Daily Clinical Practice: The TOLERANCE Study 2008 ·Cardiovascular Drug Reviews ·Vivencio Barrios, Carlos Escobar, Mariano de la Figuera, J.L. Llisterri, (unknown), J. Segura, Alberto Calderón	10
11	High doses of lercanidipine are better tolerated than other dihydropyridines in hypertensive patients with metabolic syndrome: results from the TOLERANCE study 2008 ·International Journal of Clinical Practice ·Vivencio Barrios, Carlos Escobar, Mariano de la Figuera, J. Honorato, J.L. Llisterri, J. Segura, A. Calderón	15
12	Prevalencia de la enfermedad renal crónica oculta en la población dislipémica asistida en atención primaria. Estudio LIPICAP 2008 ·Medicina Clínica ·J.L. Llisterri, J.L. Teruel, Francisco Javier Alonso Moreno, (unknown), G.C. Rodríguez Roca, Vivencio Barrios, Salvador Lou Arnal, José Ramón Banegas Banegas, (unknown)	7
13	Conducta del médico de Atención Primaria ante el mal control de los pacientes hipertensos. Estudio PRESCAP 2006 2008 ·Revista Clínica Española ·(unknown), J.L. Llisterri, (unknown), (unknown), Diego González-Segura Alsina, J.A. Divisón, José R. Banegas, Vivencio Barrios, (unknown), (unknown), J.A. Santos Rodríguez, (unknown)	21
14	Prevalencia de la hipertensión arterial en la población inmigrante asistida en atención primaria en España 2007 ·Medicina Clínica ·J.L. Llisterri, Francisco Javier Alonso Moreno, (unknown), (unknown), G.C. Rodríguez Roca, José Ramón Banegas Banegas	3
15	Adecuación del tratamiento de los pacientes hipertensos con síndrome metabólico 2007 ·Medicina Clínica ·Vivencio Barrios, Carlos Escobar, Alberto Calderón, J.L. Llisterri, Eduardo Alegría, Javier Muñiz, (unknown)	5
16	Características clínicas de los pacientes diagnosticados de insuficiencia cardíaca crónica asistidos en Atención Primaria. Estudio CARDIOPRES 2007 ·Revista Clínica Española ·G.C. Rodríguez Roca, Vivencio Barrios, (unknown), J.L. Llisterri, (unknown), Carlos Escobar, (unknown), J.A. Divisón, Nekane Murga Eizagaechevarría, (unknown)	22
17	Tratamiento y control del riesgo cardiovascular en atención primaria en España. Estudio PREVENCAT 2006 ·Medicina Clínica ·António Coca, (unknown), Enric Esmatjes, J.L. Llisterri, Jordi Ordóñez‐Llanos, Ramón Gomis, José Ramón González‐Juanatey, (unknown)	31
18	Conducta del médico de atención primaria ante el mal control de la presión arterial 2005 ·Atención Primaria ·(unknown), J.A. Divisón, J.L. Llisterri, G.C. Rodríguez Roca, (unknown), José R. Banegas, (unknown), (unknown), Vicente Gil-Guillén, (unknown)	22
19	Efectividad de la terapia combinada a dosis fijas en una cohorte de hipertensos no controlados con monoterapia 2003 ·Atención Primaria ·(unknown), J.L. Llisterri, F. J. Jiménez Jiménez, (unknown), José Vicente Lozano, R Navarro	1
20	Losartan reduces microalbuminuria in hypertensive microalbuminuric type 2 diabetics 2001 ·Nephrology Dialysis Transplantation ·(unknown), J.L. Llisterri, José Aznar, Josep Redón	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact